Leslie Asbury, MD
Otolaryngology · Versailles, KYNPI 1215054556
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.5%), travel and lodging and education — rather than concentrated in one kind of arrangement. Stryker accounts for 77.6% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2024 at $1,878 and has fallen 93.0% since, to $131 in 2025.
Across 34 payments — averaging $88.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Regeneron Healthcare Solutions, Inc.$154
- Inspire Medical Systems, Inc.$117
- Merz North America, Inc.$114
- Olympus America Inc.$105
- Biotissue Holdings Inc.$42
- plus $143 from 9 others
What the payments were for
- Travel & lodging$1,40847%
- Food & beverage$1,48849%
- Education$1124%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 13 | $2,333 |
| Regeneron Healthcare Solutions, Inc. | 4 | $154 |
| Inspire Medical Systems, Inc. | 1 | $117 |
| Merz North America, Inc. | 3 | $114 |
| Olympus America Inc. | 1 | $105 |
| Biotissue Holdings Inc. | 2 | $42 |
| Optinose US, Inc. | 2 | $28 |
| Merck | 1 | $18 |
| Sanofi | 1 | $18 |
| Johnson & Johnson | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| CSL Behring | 1 | $14 |
| Alk-abello, Inc | 1 | $12 |
| Acclarent, Inc | 1 | $12 |
| Medtronic | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,008 in reported general payments places this provider in the 70th percentile of 137 otolaryngology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 49 | $1,409 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 11 | $1,076 |
| Fluticasone Propionate | 38 | $410 |
| Nortriptyline Hcl | 21 | $266 |
| Omeprazole | 37 | $248 |
| Levothyroxine Sodium | 23 | $224 |
| Famotidine | 14 | $93 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 16 | $40 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Versailles
- Thomas HigginsLouisville$357K
- Thomas GalLexington$21K
- Andrew GouldLouisville$13K
- Steven ShottsLouisville$12K
- Keith ForwithLouisville$11K
- Skylar TrottLouisville$11K
- Brian HixonLexington$8K
- Ziad KatribLouisville$7K
- James KempinersFort Thomas$7K
- Amy IngramLouisville$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.